Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3-Way Crossover Trial Abstract Cannabidiol (CBD) is approved as an adjunctive treatment of seizures associated with Dravet syndrome, Lennox– Gastaut Syndrome, and tuberous sclerosis. Its therapeutic and adverse effects are... Epilepsy Neuromodulation TMS-EEG waveguard Aug 20, 2025 Publication